Composition for preventing and treating diabetes

Abstract

The invention provides a composition for preventing and treating diabetes, which comprises the following ingredients by weight: 1-100 parts of cinnamon, 1-100 parts of mulberry leaf, 1-100 parts of root of kudzu vine, 1-100 parts of Poria cocos, 1-100 parts of Chinese yam and 1-100 parts of bitter gourd. The composition possesses good hypoglycemic effect, and is especially suitable for preventing and treating of spleen and kidney insufficiency type diabetes.

Description

technical field [0001] The present invention relates to compositions for preventing and treating diabetes. Specifically, it relates to a composition for preventing and treating diabetes prepared from cinnamon, mulberry leaves, kudzu root, poria cocos, yam and bitter melon as main raw materials. Background technique [0002] At present, there are 285 million diabetic patients in the world, about 92.4 million diabetic patients in my country, and 148 million pre-diabetic patients. Diabetes has become the fourth leading cause of global population death. In view of the great harm that diabetes has brought to human beings, the World Health Organization called it "the disaster of the 21st century". Diabetes has a long course of disease and expensive treatment. According to statistics from the Diabetes Society of the Chinese Medical Association, the direct medical expenditure of diabetes in China has reached 173.4 billion yuan, accounting for 13% of the country's total medical expe...

AI Technical Summary

Problems solved by technology

[0003] At present, the prevention and treatment of diabetes at home and abroad mainly use chemical drugs such as biguanides, sulfonylureas, insulin and other chemical drugs, but these drugs have the following problems: biguanides have low curative effect, large side effects, and long-term use can cause hyperlactic acidemia Long-term use of sulfonylureas damages the liver and kidneys, and cross-allergy occurs with sulfonamides; long-term use of insulin produces antibodies, the biological activity decreases, and the dose increases, resulting in hyperinsulinemia

[0008] None of the above patent applications involves the treatment and prevention of spleen and kidney yang deficiency diabetes

Images